VIGNOZZI, LINDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.622
EU - Europa 8.474
AS - Asia 2.114
AF - Africa 69
SA - Sud America 24
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 21.310
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.585
RU - Federazione Russa 3.021
IT - Italia 1.678
PL - Polonia 1.340
IE - Irlanda 853
HK - Hong Kong 653
SE - Svezia 634
SG - Singapore 537
CN - Cina 440
IN - India 181
FI - Finlandia 173
DE - Germania 165
CH - Svizzera 162
GB - Regno Unito 131
UA - Ucraina 123
JO - Giordania 120
VN - Vietnam 54
CI - Costa d'Avorio 53
TR - Turchia 50
AT - Austria 40
JP - Giappone 35
CA - Canada 34
ES - Italia 33
NL - Olanda 31
FR - Francia 30
KR - Corea 19
RO - Romania 16
BE - Belgio 13
BR - Brasile 13
IR - Iran 8
AU - Australia 6
LT - Lituania 6
PH - Filippine 6
SC - Seychelles 6
MD - Moldavia 5
ZA - Sudafrica 5
AR - Argentina 4
CO - Colombia 3
GR - Grecia 3
MU - Mauritius 3
MX - Messico 3
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
EC - Ecuador 2
EE - Estonia 2
HR - Croazia 2
IL - Israele 2
MK - Macedonia 2
NG - Nigeria 2
PT - Portogallo 2
TM - Turkmenistan 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ID - Indonesia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NO - Norvegia 1
PE - Perù 1
SM - San Marino 1
Totale 21.310
Salva come PNG Salva come JPEG
Città #
Fairfield 1.736
Warsaw 1.334
Ashburn 993
Chandler 925
Dublin 849
Woodbridge 799
Seattle 745
Houston 730
Cambridge 638
Wilmington 568
Hong Kong 430
Singapore 396
Altamura 369
Lawrence 366
Ann Arbor 255
Princeton 244
Florence 230
Jacksonville 210
Moscow 160
Bern 156
Boston 145
Beijing 137
Mumbai 136
San Diego 130
Buffalo 120
Medford 112
Boardman 105
Rome 103
Shanghai 95
Milan 89
New York 70
Santa Clara 64
Falls Church 62
Kent 56
Abidjan 53
Dong Ket 46
Redwood City 43
Vienna 38
Helsinki 37
Norwalk 36
Los Angeles 33
Hillsboro 32
Okayama 30
West Jordan 29
Izmir 28
Barcelona 26
London 26
Dearborn 24
Pune 22
Andover 21
Munich 20
Bologna 19
Lappeenranta 19
Toronto 17
Guangzhou 15
Naples 15
Detroit 14
Salerno 14
Brussels 12
Redmond 12
Verona 12
Yubileyny 12
Palermo 11
Chennai 10
Seoul 10
Villanova Mondovì 10
Bremen 9
Las Vegas 9
Trieste 9
Auburn Hills 8
Messina 8
Turin 8
Bari 7
Barnet 7
Haarlem 7
Istanbul 7
Laurel 7
Lucca 7
Marciano della Chiana 7
Ottawa 7
Phoenix 7
Washington 7
Barletta 6
Bloomington 6
Camparada 6
Fontebuona 6
Forlì 6
Frankfurt Am Main 6
Haltern am See 6
Hefei 6
Omaha 6
Padova 6
Paris 6
Prescot 6
Shenzhen 6
Ankara 5
Cape Town 5
Chisinau 5
Fiesole 5
Hangzhou 5
Totale 14.527
Salva come PNG Salva come JPEG
Nome #
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 445
Metabolic syndrome and lower urinary tract symptoms: the role of inflammation 236
Negative Effects of High Glucose Exposure in Human Gonadotropin-Releasing Hormone Neurons 229
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. 226
THE USE OF TADALAFIL TO TREAT LOWER URINARY TRACT SYMPTOMS AND ERECTILE DYSFUNCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW 222
Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlates with Sexual Dysfunctions 219
Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study. 195
Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study 176
Meta-analysis of metabolic syndrome and prostate cancer 172
Androgens regulate Phosphodiesterase type 5 expression and functional activity in corpora cavernosa 171
INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function 167
Tumor Necrosis Factor α Impairs Kisspeptin Signaling in Human Gonadotropin-Releasing Hormone Primary Neurons 163
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis. 162
Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial. 156
Insulino-resistenza e fertilità nella donna con attenzione a sindrome dell'ovaio policistico (PCOS) e malattia epatica non alcoolica (NAFLD) 153
Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause. 151
Acute effects on human sperm exposed in vitro to cadmium chloride and diisoutyl-phthalate 146
Cardiometabolic Risk and Female Sexuality: Focus on Clitoral Vascular Resistance 137
Insight on the intracrinology of menopause: androgen production within the human vagina 135
Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats 134
Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men 132
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. 131
Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. 129
Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats. 124
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis 122
Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension. 121
The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery 121
The non-aromatizable androgen dihydrotestosterone (DHT) facilitates sexual behavior in ovariectomized female rats primed with estradiol. 121
Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penis. 121
METABOLIC SYNDROME-ASSOCIATED SPERM ALTERATIONS IN AN EXPERIMENTAL RABBIT MODEL: RELATION WITH METABOLIC PROFILE, TESTIS AND EPIDIDYMIS GENE EXPRESSION AND EFFECT OF TAMOXIFEN TREATMENT 120
Brain Sex Differences Related to Gender Identity Development: Genes or Hormones? 119
Psychosexual Correlates of Unwanted Sexual Experiences in Women Consulting for Female Sexual Dysfunction According to Their Timing Across the Life Span 118
Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. 118
Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits. 118
Clinical characteristics of men complaining of premature ejaculation together with erectile dysfunction: a cross-sectional study. 117
Identification, characterization and biological activity of oxytocin receptor in the developing human penis. 115
Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes. 115
Klinefelter syndrome: cardiovascular abnormalities and metabolic disorders. 115
Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia? 115
A Randomized, Placebo-Controlled Study to Assess Safety andEfficacy of Vardenafil 10 mg and Tamsulosin 0.4 mg vs. Tamsulosin 0.4 mg Alone in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. 115
Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data 115
Anti-inflammatory effects of androgens in the human vagina 113
Testosterone, cardiovascular disease and the metabolic syndrome. 112
Anti-inflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. 112
Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. 111
Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER? 111
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. 111
Hypogonadotropic hypogonadism and metabolic syndrome: insights from the high-fat diet experimental rabbit animal model 111
Benign prostatic hyperplasia: a new metabolic disease? 110
Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study. 109
FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS. 107
5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature 107
Global Consensus Position Statement on the Use of Testosterone Therapy for Women 106
Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements. 105
Nomegestrol acetate/17beta-estradiol does not negatively alter the vascular resistance of clitoral arteries: a prospective, exploratory study 105
Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes. 104
Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis. 104
Klinefelter's Syndrome: A Clinical and Therapeutical Update 104
Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction 104
Treatment of Functional Hypogonadism Besides Pharmacological Substitution 104
Beneficial effects of bile acid receptor agonists in pulmonary disease models. 104
Validation of a Visual Analogue Scale to measure the subjective perception of orgasmic intensity in females: The Orgasmometer-F 103
Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. 102
PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH 102
Risks and benefits of late onset hypogonadism treatment: an expert opinion 102
Role of Sexuality in the Outcome of Anorexia Nervosa and Bulimia Nervosa: A 3-Year Follow-Up Study 102
Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. 101
BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder. 101
Which are the male factors associated with female sexual dysfunction (FSD)? 101
Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound. 101
Neural Correlates of Gender Face Perception in Transgender People 101
Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway. 100
CHILDHOOD SEXUAL ABUSE MODERATES THE RELATIONSHIP BETWEEN SEXUAL FUNCTIONING AND EATING DISORDER PSYCHOPATHOLOGY IN ANOREXIA NERVOSA AND BULIMIA NERVOSA: A 1-YEAR-FOLLOW-UP STUDY. 100
Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. 99
Which patients with sexual dysfunction are suitable for testosterone replacement therapy? 99
Characterization and functional role of androgen-dependent PDE5 activity in the bladder. 98
Testosterone protects from metabolic syndrome-associated prostate inflammation: An experimental study in rabbit 98
Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility 97
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome 97
Anorectic and Bulimic Patients Suffer from Relevant Sexual Dysfunctions. 97
Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. 96
Outcome of Medical and Psychosexual Interventions for Vaginismus: A Systematic Review and Meta-Analysis. 96
The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder 95
Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. 95
Human prostatic urethra expresses Vitamin D receptor and responds to Vitamin D receptor ligation. 95
Metabolic syndrome and prostate abnormalities in male subjects of infertile couples 94
Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model. 94
Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit. 94
A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. 93
Management of benign prostatic hyperplasia: role of phosphodiesterase-5 inhibitors. 93
Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model 93
Obesity and hormonal contraception: an overview and a clinician's practical guide 92
Peripheral regulatory mechanisms in erection 92
Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat. 91
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial 91
Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit. 91
Serum PSA as a Predictor of Testosterone Deficiency. 90
Testosterone therapy in men with Crohn's disease improves the clinical course of the disease: data from long-term observational registry study. 90
Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model. 89
Endocrine control of ejaculation 89
Totale 12.225
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.061
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.974 0 0 0 266 422 404 420 433 389 234 315 91
2020/20212.598 197 221 134 418 127 257 139 184 246 354 163 158
2021/20222.029 85 205 301 61 55 77 74 235 96 82 316 442
2022/20234.444 387 995 168 268 290 711 523 224 392 131 122 233
2023/20242.636 72 178 366 132 202 237 181 642 103 245 181 97
2024/20254.190 511 1.320 891 1.468 0 0 0 0 0 0 0 0
Totale 21.964